Gallery

Every year, ESCMID members are celebrated with grants and awards. Here, you can read more about some of the awardees below.

ESCMID is, to me, the backbone of international clinical microbiology and infectious diseases.

Gunnar Kahlmeter
ECCMID 2023 Excellence Award

This award has increased my motivation to keep doing research.

Jacob Bodilsen
ECCMID Young Investigator Award 2023

I believe that everyone should find their true passion.

Belén Gutiérrez-Gutiérrez
ESCMID Young Investigator Awards 2023

Awardees 2024

  Nathan Brendish

Nathan Brendish

Southampton General Hospital
United Kingdom
  Pieter De Cock

Pieter De Cock

Ghent University
Belgium
  Henning Grüll

Henning Grüll

University Hospital Cologne
Germany
  Rasmus Leistner

Rasmus Leistner

Charité Universitätsmedizin Berlin
Germany
  Ira Praharaj

Ira Praharaj

Indian Council of Medical Research (ICMR)
India
  Evelina Tacconelli

Evelina Tacconelli

EUCIC Chairperson
University of Verona
Verona, Italy
  Akshatha Ravindra

Akshatha Ravindra

AIIMS Jodhpur
India
  Marija Kusulja

Marija Kusulja

University Hospital for Infectious Diseases Zagreb
Croatia
  Bieke Tack

Bieke Tack

KU Leuven University
Belgium

Applicant name

Applicant Origin

Project title

Ana Luísa Abrantes de Matos

Coimbra, Portugal

Diving into Rickettsia's Immune-Evasion Arsenal: Unveiling the Moonlighting Role of the Retropepsin APRc

Michael Savin-Hoffmeyer

Bonn, Germany

Clinical Wastewater as a Surveillance Tool: A Study on Cefiderocol-Resistant Bacteria and Resistance Dissemination via Transformation

Rita Pombinho

Porto, Portugal

Single-cell spatiotemporal analysis of Listeria monocytogenes virulence gene expression during infection

Eliza Gil

London, United Kingdom

Deciphering the determinants of virulence in Streptococcus intermedius

Kaitlin Winter

Vancouver, Canada

Addressing antimicrobial resistance through a Klebsiella pneumoniae vaccine

Rachel Clifton

Loughborough, United Kingdom

The role of interspecies bacterial interactions in ovine footrot

Zaynab Mousavian

Stockholm, Sweden

Biomarker discovery in Tuberculosis using high-throughput protein profiling and systems biology

Sacha Sarfati

Paris, France

Impact of the gut microbiota on Listeria monocytogenes intestinal carriage

Johanna Strobl

Vienna, Austria

Tick saliva facilitates Borrelia burgdorferi transmission to human skin - a role for tolerogenic Langerhans cells?

Carl Boodman

Winnipeg, Canada

Investigating Bartonella quintana as a neglected infection among individuals experiencing poverty using active case finding, novel sampling techniques and bacterial sequencing

Palmira Barreira-Silva

Porto, Portugal

Characterization of the AHR-responsive cellular profile during Mycobacterium tuberculosis infection

Julia García Fernández

Madrid, Spain

Unveiling the Interplay of Mutagenesis, Metabolism, and Competence in Staphylococcus aureus Pathogenesis

Shakeel Mowlaboccus

Perth, Australia

Elucidating the Molecular Mechanism of Transiently Silent Vancomycin Resistance in Enterococcus faecium

Frédéric Goormaghtigh

Sint-Lambrechts-Woluwe, Belgium

Interrogating the transcriptional histories of antibiotic-persistent S. aureus in macrophages using a molecular recorder

Liliana Oliveira

Porto, Portugal

CD5L as a new therapy for bacterial sepsis

Carolina Silva Nodari

Paris, France

Evaluation of the potential use of intimin and flagellar antigen types as molecular markers for the diversity of enteropathogenic Escherichia coli (EPEC) populations

Victor Næstholt Dahl

Risskov, Denmark

Tuberculosis 2.0: The clinical significance of nontuberculous mycobacteria isolation in Denmark

Anne Kathrin Lösslein

Freiburg, Germany

The role of stromal cells in mycobacterial infections

Thomas Kesteman

Hanoi, Viet Nam

Adapting MSF’s Mini-Lab to the local context to provide access to remote hospitals in Vietnam

Inês Loureiro

Porto, Portugal

Bioengineered Photobacterium OMVs as a platform for producing multivalent fish vaccines

Ana Fernández Bravo

Reus, Spain

The genus Aeromonas as a model of polymicrobial infections: impact on pathogenesis, host immune response and the antimicrobial therapy.

Nasreen Hassoun-Kheir

Geneve, Switzerland

How to measure the association between appropriateness of antibiotic treatment and clinical outcomes of patients with drug-resistant bloodstream infections

Roberto Vázquez

Ghent, Belgium

Development of phage-inspired coupled diagnostics and targeted antibacterials against streptococci

Damian Lobato-Marquez

Madrid, Spain

Identifying bacterial factors that subvert cell-autonomous immunity to promote infection

Emily Stevens

Oxford, United Kingdom

Investigating the role of host microbiota in the transition of Staphylococcus aureus from benign commensal to major human pathogen

Consuelo Micheli

Braga, Portugal

Unveiling tuberculosis susceptibility: the key role of alveolar macrophages

Sue Chin Nang

Clayton, Australia

Advancing Personalised Bacteriophage Therapy with “One-stop” Digital PCR Integrated Cell-free Platform

Marta Silva

Porto, Portugal

Tuberculosis hide and seek: lessons from M. tuberculosis L4 and L6 mixed infections

Anne-Lise Beaumont

Clichy, France

Plasmid-mediated vertical transmission of ESBL-producing Enterobacteriaceae in a bicentric mother-neonate cohort (Madagascar and Cambodia)

Elsa Feredj

Créteil, France

Understanding susceptibility to tuberculosis through the identification and functional characterization of novel genetic etiologies

Anna Griego

Milan, Italy

Unraveling the intricate dance: TLR2 Signaling in Mycobacterium tuberculosis infection

Alina Karoline Nussbaumer-Pröll

Wien, Österreich, Austria

Investigating the Genotypic and Phenotypic Properties of ATCC-29213 Quality Control Strain in Ten European Laboratories

Elif Eren

Istanbul, Turkey

Identification of A New Host Protein-Hijacking Mechanism Used by Salmonella Typhimurium

Sónia Almeida

Oeiras, Portugal

CAPSMi – Characterization of the diversity of Streptococcus pneumoniae-like capsules expressed by other streptococci and impact on pneumococcal diagnosis and epidemiology

Filippo Vascon

Padova (PD), Italy

Nanobodies blocking Shiga toxin production in enterohemorrhagic Escherichia coli

Eva Gato

Madrid, Spain

Preclinical development of plasmid DNA-based vaccine against intestinal colonization caused by Klebsiella pneumoniae.

Eleni Vergadi

Heraklion, Greece

Unravelling the role of antibacterial autophagy in the host defense response to Group B Streptococcus

Sabine Wagner-Lichtenegger

Graz, Austria

Improving Nanopore Sequencing based core genome MLST for global infection control

Applicant name

SG

Project Title

Joana Azeredo

ESGB

Minimum information guidelines and standards to assess the susceptibility of biofilms to therapeutic bacteriophages

Angela Novais

ESGEM, ESGMD

Development and Validation of Fourier transform infrared (FT-IR) spectroscopy for rapid typing of multidrug resistant Escherichia coli and infection control

Guido Werner

ESGMD, ESGARS

Assessing Prevalence, Population structure and resistance mechanisms of Linezolid-resistant Enterococci – a multicenter study 2023 (APPLE 2023)

Linda Veloo

ESGAI

Mapping Horizontal Gene Transfer, within a clinical specimen, between anaerobes and/or aerobes

Sue Nang

ESGNTA

Exploring the Intricacies of Phage-Antibiotic Therapy through Pharmacokinetic/Pharmacodynamic Modelling and Systems Biology

Jannie Henderickx

ESGHAMI

The archaeal community of the gut microbiota in Parkinson’s Disease

Antonio Rivero-Juarez

ESGVH

Current aetiology of prosthetic joint infections (CAPJI)

Applicant name

Stung Groups

Project Title

Michael Beeton

ESGMAC, ESGEM, ESGMD

Developing a novel method for assessing global genetic diversity and molecular surveillance of Mycoplasma pneumoniae during its re-emergence after the COVID-19 pandemic and beyond.